Please try another search
For the three months ended 31 March 2022, biote Corp revenues was not reported. Net income totaled $1.2M vs. loss of $3.9M. Net income reflects Excess of private placement warrant fair decrease from $3.5M (expense) to $0K, Change in fair value of warrant liab increase from $620K to $2.4M (income), Transaction costs allocated to warrant l decrease from $962K (expense) to $0K.
Period Ending: | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
---|---|---|---|---|
Total Revenue | 41.36 | 37.14 | 0 | |
Gross Profit | 27.82 | 24.87 | ||
Operating Income | -66.8 | 10.46 | -0.29 | |
Net Income | 115.46 | 0 | 3 |
Period Ending: | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
---|---|---|---|---|
Total Assets | 115.32 | 59.42 | 54.33 | 318.23 |
Total Liabilities | 218.83 | 48.68 | 50.2 | 22.19 |
Total Equity | -103.51 | 10.75 | 4.12 | 296.05 |
Period Ending: | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 9 Months |
Cash From Operating Activities | -28.57 | 6.97 | -1.21 | |
Cash From Investing Activities | -0.658 | -0.482 | -317.5 | |
Cash From Financing Activities | 84.26 | -5.56 | 319 | |
Net Change in Cash | 55.02 | 0.939 | 0.29 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review